Oruka Therapeutics (ORKA) Assets Growth (3y) (2013 - 2026)
Oruka Therapeutics (ORKA) Assets Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oruka Therapeutics | 36.09 Mn | -795.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 128.91% |
| Dec 31, 2025 | 124.67% |
| Sep 30, 2025 | 124.57% |
| Jun 30, 2025 | 95.14% |
| Mar 31, 2025 | 94.80% |
| Dec 31, 2024 | 93.19% |
| Sep 30, 2024 | 90.19% |
| Jun 30, 2024 | -19.69% |
| Mar 31, 2024 | -19.04% |
| Dec 31, 2023 | -9.11% |
| Sep 30, 2023 | -8.99% |
| Jun 30, 2023 | 52.28% |
| Mar 31, 2023 | 77.97% |
| Dec 31, 2022 | 71.54% |
| Sep 30, 2022 | 65.34% |
| Jun 30, 2022 | 66.68% |
| Mar 31, 2022 | 80.98% |
| Dec 31, 2021 | 100.39% |
| Sep 30, 2021 | 92.45% |
| Jun 30, 2021 | 86.53% |